CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 57 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-20 | CARR EDWARD Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +51,081 | 51,081 | ||
| 2020-11-20 | CARR EDWARD Chief Accounting Officer | Returned to the company · Stock Option (right to buy) | −51,081 | 0 | ||
| 2020-11-20 | CARR EDWARD Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2020-11-20 | CARR EDWARD Chief Accounting Officer | Returned to the company · Stock Option (right to buy) | −10,000 | 0 | ||
| 2020-11-20 | CARR EDWARD Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2020-11-20 | CARR EDWARD Chief Accounting Officer | Returned to the company · Stock Option (right to buy) | −35,000 | 0 | ||
| 2020-11-20 | Rouhandeh Steven H Director | Grant or award · Stock Option (right to buy) | +86,756 | 86,756 | ||
| 2020-11-20 | Rouhandeh Steven H Director | Returned to the company · Stock Option (right to buy) | −86,756 | 0 | ||
| 2020-11-20 | Rouhandeh Steven H Director | Grant or award · Stock Option (right to buy) | +153,244 | 153,244 | ||
| 2020-11-20 | Rouhandeh Steven H Director | Returned to the company · Stock Option (right to buy) | −153,244 | 0 | ||
| 2020-11-20 | Rouhandeh Steven H Director | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2020-11-20 | Rouhandeh Steven H Director | Returned to the company · Stock Option (right to buy) | −120,000 | 0 | ||
| 2020-11-20 | Rouhandeh Steven H Director | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2020-11-20 | Rouhandeh Steven H Director | Returned to the company · Stock Option (right to buy) | −120,000 | 0 | ||
| 2020-11-20 | Rouhandeh Steven H Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2020-11-20 | Rouhandeh Steven H Director | Returned to the company · Stock Option (right to buy) | −200,000 | 0 | ||
| 2020-11-20 | Rouhandeh Steven H Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2020-11-20 | Rouhandeh Steven H Director | Returned to the company · Stock Option (right to buy) | −200,000 | 0 | ||
| 2020-11-20 | Rouhandeh Steven H Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2020-11-20 | Rouhandeh Steven H Director | Returned to the company · Stock Option (right to buy) | −125,000 | 0 |
Page 16 of 23 · 443 trades